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ABSTRACT: Stable isotope dilution mass spectrometry (MS)
represents the gold standard for quantiﬁcation of endogenously
formed cellular metabolites. Although coenzyme A (CoA) and
acyl-CoA thioester derivatives are central players in numerous
metabolic pathways, the lack of a commercially available iso-
topically labeled CoA limits the development of rigorous MS-
based methods. In this study, we adapted stable isotope labeling by amino acids in cell culture (SILAC) methodology to bio-
synthetically generate stable isotope labeled CoA and thioester analogues for use as internal standards in liquid chromatography/
multiplereactionmonitoringmassspectrometry(LC/MRM-MS)assays.Thiswasaccomplishedbyincubatingmurinehepatocytes
(Hepa 1c1c7) in media in which pantothenate (a precursor of CoA) was replaced with [
13C3
15N1]-pantothenate. Eﬃcient
incorporation into various CoA species was optimized to >99% [
13C3
15N1]-pantothenate after three passages of the murine cells in
culture. Charcoal-dextran-stripped fetal bovine serum (FBS) was found to be more eﬃcient for serum supplementation than
dialyzed or undialyzed FBS, due to lower contaminating unlabeled pantothenate content. Stable isotope labeled CoA species were
extracted and utilized as internal standards for CoA thioester analysis in cell culture models. This methodology of stable isotope
labeling by essential nutrients in cell culture (SILEC) can serve as a paradigm for using vitamins and other essential nutrients to
generate stable isotope standards that cannot be readily synthesized.
C
oenzyme A (CoA), a ubiquitous and essential cofactor, is
recognized to play a central role in numerous metabolic
pathways
1 from fatty acid metabolism to xenobiotic acetylation.
2
More recently, it has been shown that levels of CoA species are
perturbed in many pathological settings including diabetes,
3,4
hyperoxia,
5,6 seizures,
7a n dv a r i o u si n h e r i t e dm e t a b o l i cd i s o r d e r s .
8-13
Therefore, robust and speciﬁc methods are required in order to
accurately quantify CoA and its thioester derivatives in cell and
tissue samples. Stable isotope dilution liquid chromatography/
multiple reaction monitoring mass spectrometry (LC/MRM-
MS) represents the gold standard for the quantiﬁcation of intra-
cellularmetabolites.
14Unfortunately,abroadstableisotopedilu-
tionmethodtomeasureawidevarietyofCoAthioestersdoesnot
exist due to the lack of a commercially available isotopically
labeled CoA.
15 As a result, stable isotope methods to quantify
CoA and its derivatives have been limited to those in which an
isotopically labeled thioester is available.
16,17
We have developed a biosynthetic method to generate iso-
topicallylabeledCoAanditsthioesterderivatesusinganapproach
similar to the stable isotope labeling by amino acids in cell culture
(SILAC) method, which was developed by Ong et al.
18 SILAC
methodology involves incubating cells through multiple passages
inthepresenceofisotopicallylabeledessentialaminoacids,
19,20to
generate labeled protein internal standards. The use of SILAC
methodology to prepare stable isotope labeled proteome stan-
dards has signiﬁcantly improved the ﬁeld of quantitative prote-
omics.
14,21-23 Analogous to essential amino acids, there are also
essentialnutrientssuchaspantothenate(vitaminB5),awater-soluble
vitamin precursor of CoA, that cannot be biosynthesized by
mammals. After cellular uptake of pantothenate, a ﬁve-step
enzymatic pathway is used to synthesize CoA (Figure 1).
1 Since
mammalsareincapable ofpantothenatesynthesis,itisarequired
cofactor in mammalian cell culture media. By incubating cells in
media containing [
13C3
15N1]-pantothenate instead of unlabeled
pantothenate, we have developed the stable isotope labeling by
essential nutrients in cell culture (SILEC) method for eﬃciently
labeling CoA and its thioester derivatives analogous to the
SILAC method used for labeling proteins.
’EXPERIMENTAL SECTION
Chemicals and Reagents. Reduced CoA (CoASH), acetyl-
CoA,succinyl-CoA,3-hydroxy-3-methylglutaryl-CoA(HMG-CoA),
propionyl-CoA, 5-sulfosalicylic acid (SSA), and trichloroacetic acid
(TCA) werepurchasedfromSigma-Aldrich(St.Louis,MO).RPMI
1640 pantothenate-omitted media was purchased from Athena
Environmental Sciences (Baltimore, MD). Undialyzed fetal bo-
vineserum(uFBS),dialyzedFBS(dFBS),andcharcoal-dextran-
strippedFBS (csFBS) werepurchasedfrom GeminiBio-Products
(West Sacramento, CA). All solvents used were Optima grade
(Fisher Scientific, Pittsburgh, PA). [
13C3
15N1]-pantothenate was
purchased from IsoSciences (King of Prussia, PA).
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Cell Culture and Extraction of Short-Chain CoA Thioe-
sters. Murinehepatocytes(Hepa1c1c7,ATCCno.CRL-2026)
were maintained in RPMI 1640 media supplemented with 10%
FBS,2 mM L-glutamine, 100units/mLpenicillin, and100μg/mL
streptomycinat37Cand5%CO2.ExtractionofCoAspecieswas
performed using modifications to similar methods.
15,16,24 Briefly,
cellswerewashedtwicewith10mLofice-coldphosphate-buffered
saline (PBS). Cells were harvested by scraping into 1 mL of
PBS. A 100 μL aliquot was saved for protein quantification, and
the remainder was pelleted at 1000g. The cell pellet was resus-
pended in 1 mL of ice-cold 10% TCA and pulse-sonicated for
30soniceusingasonicdismembranator(Fisher),followedbya
5mincentrifugationat15000g.Thesupernatantwastransferred
to a fresh tube, and the pellet was discarded. The supernatant
was purified by solid-phase extraction as follows: Oasis HLB
1c m
3 (30 mg) SPE columns (Waters) were conditioned with
1 mL of methanol followed by 1 mL of water. The collected
supernatant was applied, washed with 1 mL of water, and finally
eluted using three subsequent applications of 0.5 mL of metha-
nol containing 25 mM ammonium acetate. Eluted compounds
weredrieddownundernitrogenandresuspendedin100μLof5%
5-SSA.Injectionsof10μLweremadeforliquidchromatography/
electrospray ionization mass spectrometry (LC/ESI-MS)
analysis.
LC/MS. Analytes were separated using a reversed-phase Phe-
nomenex HPLC Luna C18 column (2.0 mm   150 mm, pore
size5μm)with5mMammoniumacetateinwaterassolventA,5
mM ammonium acetate in 95/5 acetonitrile/water (v/v) as
solventB,and80/20/0.1(v/v/v)acetonitrile/water/formicacid
as solvent C. Gradient conditions were as follows: 2% B for 1.5
min, increased to 25% over 3.5 min, increased to 100% B in 0.5
min and held for 8.5 min, washed with 100% C for 5 min, before
equilibration for 5 min. The flow rate was 200 μL/min. Samples
wereanalyzedusinganAPI4000triple-quadrupolemassspectro-
meter (Applied Biosystems, Foster City, CA) in the positive ESI
mode. Samples (10 μL) were injected using a Leap CTC auto-
sampler (CTC Analytics, Switzerland) where they were main-
tained at 4 C, and data was analyzed with Analyst 1.4.1 software.
The column effluent was diverted to the mass spectrometer from
8 to 13 min and to waste for the remainder of the run. The mass
spectrometer operating conditions were as follows: ion spray
voltage (5.0 kV), nitrogen as curtain gas (15 units), ion source
gas1(8units),gas2(15units),andcollision-induceddissociation
(CID) gas (5 units). The ESI probe temperature was 450 C, the
declusteringpotential was 105 V, the entrancepotentialwas 10 V,
the collision energy was 45 eV,and thecollision exit potentialwas
15 V. Isotopic labeling using [
13C3
15N1]-pantothenate resulted in
Figure 1. Metabolic pathway for CoA biosynthesis from pantothenate
(vitamin B5). Enzymes: (A) pantothenate kinase (rate-limiting); (B)
phosphopantothenoyl cysteine synthetase; (C) phosphopantothenoyl
cysteine decarboxylase; (D) phosphopantetheine adenylyltransferase;
(E) dephospho-CoA kinase. [
13C] and [
15N] atoms are marked in red.
Table 1. MRM Transitions for Short-Chain CoA Thioesters
and Stable Isotope Labeled Analogues Prepared by SILEC
compound parent (m/z) daughter (m/z)
CoASH 768.1 261.1
[
13C3
15N1]-CoASH 772.1 265.1
acetyl-CoA 810.1 303.1
[
13C3
15N1]-acetyl-CoA 814.1 307.1
propionyl-CoA 824.1 317.1
[
13C3
15N1]-propionyl-CoA 828.1 321.1
succinyl-CoA 868.1 361.1
[
13C3
15N1]-succinyl-CoA 872.1 365.1
HMG-CoA 912.1 405.1
[
13C3
15N1]-HMG-CoA 916.1 409.1
Figure 2. LC/constant neutral loss MS analysis of hepatocytes extracts
with a neutral loss of m/z 507 showing CoA (MH
þ, m/z 768), acetyl-
CoA(MH
þ,m/z810),propionyl-CoA(MH
þ,m/z824),succinyl-CoA
(MH
þ, m/z 868), and HMG-CoA (MH
þ, m/z 912).1365 dx.doi.org/10.1021/ac1027353 |Anal. Chem. 2011, 83, 1363–1369
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labeled CoA and thioester derivatives with a mass shift of 4 amu.
Transitions employed for LC/MRM-MS analyses are shown in
Table 1.
Stable Isotope Labeling Using [
13C3
15N1]-Pantothenate.
Labeling of CoA and its thioesters was achieved using a proce-
dure similar to SILAC except that [
13C3
15N1]-pantothenate was
used instead of deuterated amino acids.
18 Murine hepatocytes
were cultured in RPMI media containing 1 mg/L [
13C3
15N1]-
pantothenate and 10% serum (uFBS, dFBS, or csFBS). To
monitor labeling efficiency, cells were harvested at each passage
and processed as described above. The ratio of unlabeled to
labeledreducedCoA(CoASH)wasusedtomonitorlabelingand
to calculate absolute concentrations of pantothenate (Support-
ing Information Supplemental Table 1). To characterize pan-
tothenate labeling, cells were grown to confluence, washed and
treated with the labeling media for 0, 1, 3, 6, 12, 18, or 24 h, fol-
lowed by harvesting and extraction. CoA labeling and scale-up
were optimized by varying the type of serum (uFBS, dFBS, and
csFBS) as wellas theconcentrationof [
13C3
15N1]-pantothenate,
supplemented into the labeling media. After scale-up (as des-
cribed below), cells were harvested by scraping and sonicationin
10% TCA. Acidified extracts containing stable isotope labeled
CoAthioesterswerepooled,aliquoted,frozen,storedat-80C,
and thawed as needed.
Scale-Up of Stable Isotope Labeling of CoA and Its
Thioesters. Cells were split 1:5, collected, and processed each
day for seven days. Although there was some minor variation
among different CoA species, the peak level for each of the CoA
species occurred on day 4 or 5 (Supporting Information Supple-
mental Table 2). Therefore, a two-step approach was employed.
First, cells were grown in media supplemented with 10% csFBS
and 1 mg/L [
13C3
15N1]-pantothenate for three passages. Sec-
ond, the media was replaced on the third day of the final passage
with media containing 3 mg/L labeled pantothenate and 3%
csFBS. The incubation was continued overnight; cells were then
harvested and processed the next day. This resulted in efficient
labeling of all CoA species to >99% labeling. Typically this was
conducted using 20 plates or more.
Validation. Cells from 20 plates were sonicated in 10% TCA
(0.5 mL per plate), pooled, and aliquoted into three fractions of
3 mL, which were subsequently stored at -80 C. Lysates from
[
13C3
15N1]-pantothenate-labeled cells were prepared as de-
scribed above and also stored at -80 C. CoASH and short-
chain acyl-CoA standards were stored in 5% SSA at -80 C. For
thestandardcurve,CoAstandardswerethawedanddilutedusing
10% TCA, each with a final volume of 0.5 mL. One 3 mL cell
lysate aliquot was thawed each day of the validation and divided
intosix0.5mLaliquots.Eachstandardorfractionwasmixedwith
0.5 mL of the labeled CoA TCA lysate. Samples were processed
as described above. Intraday and interday validation was per-
formed for each analyte.
Propionate Treatment. Propionate treatment was used to
demonstratechangesinintracellularCoAthioesterconcentrations
in Hepa 1c1c7 cells. Cells were grown to approximately 90%
confluence in 10 cm tissue culture dishes. Prior to treatment, cells
were washed twice with PBS. Cells were then treated with HBSS
supplemented with CaCl2,M g S O 4,g l u c o s e ,2 5m MH E P E S
buffer, and 10 mM propionate. Control cells were treated with
thesamemedia,excludingpropionate.Cellswereincubatedinthe
treatment media for 1 h and processed as described previously.
’RESULTS AND DISCUSSION
LC/ESI-MS/MS and CoA Extraction. Although many LC/
MS methods have been developed to analyze CoA thioester
speciesinplant
25,26andanimaltissues,
15-17,27-29thefocusofour
studyisusingmammaliancellculturemodels,whichoftenrequire
increased sensitivity.
24,30,31 CoA and short-chain CoA thioesters
wereidentifiedincellularextractsusingaconstantneutrallossscan
of m/z 507 amu corresponding to the ATP moiety (Figure 2).
Figure 3. Analysisofshort-chain CoA thioesters. LC/MRM-MS chromatograms of(A)CoAthioester standards (1pmoleach)and(B)acidic extracts
from 1 plate of Hepa 1c1c7 cells.1366 dx.doi.org/10.1021/ac1027353 |Anal. Chem. 2011, 83, 1363–1369
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MRM transitions were developed for five unlabeled and labeled
CoA thioesters (Table 1) in order to conduct sensitive quanti-
tative LC/MS analysis (Supporting Information Supplemental
Figure 1). However, this SILEC technique can be extended to
other CoA thioesters by making modifications to the extraction
procedure.
32Duetothesimilarityofthevariousshort-chainCoA
thioesters, LC/MRM-MS analysis was employed for specific
identification as well as accurate and precise quantification of
thevariousCoAspecieswithoutrequiringabsolutebaselinesepa-
ration as is needed for HPLC-UV methods.
33,34 CoA standards
and acid-extracted CoA thioesters from hepatocytes were sepa-
rated and quantified using LC/MRM-MS (Figure 3).
Stable Isotope Labeling with [
13C3
15N1]-Pantothenate.
Stable isotope labeled CoA thioester derivatives were generated
by growing cells in pantothenate-omitted media supplemented
with [
13C3
15N1]-pantothenate. To verify and characterize the
incorporation of labeled pantothenate into acyl-CoA species,
cells were grown in labeled media, harvested at different times,
and processed (Figure 4). Various CoA species and their heavy-
labeledisotopesweremonitoredtoassesstherelativeamountsof
labeling. The ratio of labeled to unlabeled CoA was consistent
throughout all analyzed CoA thioesters. Labeled CoASH could
be detected as early as 3 h, replacing approximately 4% of the
CoASHinthecellseveryhour. After12h,thereappearedtobea
labeling “plateau”, likely the result of an active or sequestered
CoA pool unavailable for turnover.
Like SILAC methodology, labeling eﬃciency is dependent on
therelativeconcentrationoflabeledtounlabeledsubstrateinthe
media.As such, minimizing unlabeledpantothenateinthemedia
is critical for the production of pure isotopically labeled CoA
standards. Since circulating vitamins represent a major source of
contaminating unlabeled pantothenate in serum-supplemented
cell culture, three diﬀerent types of sera were tested: undialyzed
(uFBS),dialyzed(dFBS),andcharcoal-dextran-stripped (csFBS).
Although dFBS and csFBS are both often used in many cell culture
applications to decrease interbatch variation, dialysis uses only size
ﬁltration, whereas stripping serum with activated charcoal more
speciﬁcally binds and depletes certain small molecules such as
steroids,
35 peptide hormones, and vitamins.
36 We found that
maximal labeling was achievedby thethird passagewithminimal
increases in labeling with additional passages (Table 2). csFBS
wasdeterminedtobethemosteﬃcientforourapplicationdueto
its lower pantothenate content. The maximal achievable steady
state of labeled CoA represents the percentage of labeled panto-
thenate to total pantothenate in the media. By determining the
percentage of CoA that is labeled within the cells, the approx-
imate concentration of unlabeled contaminating pantothenate
wascalculatedanddeterminedtobethefollowing:uFBS(5.7mg/
L), dFBS (0.21 mg/L), and csFBS (0.092 mg/L) (Supporting
Information Supplemental Table 1).
Scale-Up of Stable Isotope Labeling of CoA and Its
Thioesters. ToincreasethepurityofthelabeledCoAstandards,
two techniques were employed: (A) increasing the amount of
[
13C3
15N1]-pantothenate in the media or (B) decreasing the
amount of serum. Decreasing the FBS concentration resulted in
significantly slowed growth characteristics, while further increases
inmediasupplementationof[
13C3
15N1]-pantothenateresultedin
limitingreturnsonlabeling.Byutilizingatwo-stepapproachusing
10% csFBS initially followed by a final incubation with 3% csFBS,
efficientscale-upwasachievedwhilelimitingtheamountoflabeled
pantothenate that was required.
Other approaches to generating heavy-labeled CoA are pos-
sible, though less optimal. Since CoA contains pantothenate,
cysteine, and ATP, labeling with cysteine or a heavy-labeled
carbonsourcewouldalsoresultinlabeledCoA.Onelimitationof
cysteine labeling is that this can be synthesized de novo, which
would result in decreased isotopic purity of the compound.
Since only a small fraction of cysteine or carbon from isotopic
nutrientsourcesisincorporatedintoCoA,thesemethodsareless
eﬃcient than the described method, where nearly all of the
pantothenate is incorporated into CoA. Furthermore, prepara-
tion of [
13C3
15N1]-analogues avoids problems that can arise
throughthemetabolicinstabilityofdeuteriumandtheseparation
Figure4. StableisotopelabelingofCoAthioestersinHepa1c1c7cellsgrownin[
13C3
15N1]-pantothenate(1mg/L).(A)LC/constantneutrallossMS
analysiswithaneutrallossofm/z507fromhepatocytesextractsafter24hofpantothenatelabeling.(B)Timecourseofpantothenateincorporationinto
CoASH using LC/MRM-MS analysis.
Table2. EﬀectofDiﬀerentSeraonStableIsotopeLabelingof
CoA
a
passage no.
serum 1 2 3 4 5
uFBS 59.3 59.8 55.9 58.7 63.4
dFBS 93.5 97.6 97.7 97.4 97.9
csFBS 94.6 98.4 98.9 99.0 99.1
aPercentage of labeled CoASH in Hepa 1c1c7 cells serially passaged in
pantothenate-omitted RPMI 1640 media supplemented with 1 mg/L
[
13C3
15N1]-pantothenate and 10% serum: uFBS, dFBS, csFBS.1367 dx.doi.org/10.1021/ac1027353 |Anal. Chem. 2011, 83, 1363–1369
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of deuterium and protium analogues that occurs during LC/MS
analysis.
37-39 Finally, methods using stable isotope CoA com-
pounds with labeled acyl moieties are limited to those in which
such labeled thioesters are available.
16 If a large number of CoA
species are quantiﬁed, this would require labor-intensive prepara-
tionofeachstandardindividually. Also, labeled CoASH couldnot
be produced using this methodology. In contrast, biosynthetic
generation of CoA thioesters provides simultaneous synthesis
of every labeled thioester standard in a particular cell type in a
naturally occurring proﬁle in the appropriate concentration range
tobeusedinthestudy.Moreover,diﬀerentinternalstandardmix-
tures could be readily generated for speciﬁc applications by treat-
ing the labeled cells with a precursor fatty acid to reﬂect more
appropriate thioester concentrations (Figure 5).
Assay Validation. Validation was performed on various CoA
thioestersusingourSILEC-derivedinternalstandards(Table3).
Extractedsamples were quantifiedwithandwithout SILEC stan-
dards. Specificity was also improved since the compounds were
coeluting with their standards. More importantly, it was found
thatusingstableisotopeanaloguesasinternalstandardsprovided
a significant improvement in accuracy and precision when com-
paredwithnonidenticalinternalstandards(Supporting Informa-
tion Supplemental Table 3). The approach more commonly
employed involves using a nonlabeled compound that is similar,
but distinct, from the analyte of interest as the internal standard.
There are several drawbacks to using this type of method. First,
using an internal standard that is different than the analyte of
interest assumes that both analyte and internal standard will
behave equally throughout the assay. Although this may be a
reasonable assumption for closely related compounds, as com-
poundsdivergechemically,theyalsowillshowagreaterdisparity
intheirbehavior.Second,ESIisparticularlysusceptibletomatrix
effects, due to the limited amount of ionization that can occur at
the source. These effects can lead to an under- or overestimation
of certaincompounds as theycoelute inacomplex mixture.
40-42
Matrixeffectsarenonlinearandcanvarydramaticallythroughout
a gradient run, particularly when analyzing tissue samples. Finally,
analyte stability and loss during sample preparation can vary
considerablyfor differentCoA species. Therefore, theassumption
that the measured analyte will have the same stability as the ana-
logue internal standard may also lead to over- or underestimation
of the compound. Additionally, the stable isotope can act as a
carrier for trace analytes and improve sensitivity.
Application of SILEC Standards for CoA Thioester Quanti-
fication in Cell Culture. Propionate incorporation into propio-
nyl-CoA in Hepa 1c1c7 cells was used as a model for CoA
metabolism.
43 Due to the wide disparity of CoA thioesters
concentrations in treated compared to untreated cells, an optimal
“customized” internal standard mixture was generated by combin-
ing the CoA extracts from untreated SILEC cells and an equal
numberofpropionate-treatedSILECcells(Figure5).Thisinternal
standard contained an acyl-CoA profile more applicable to both
experimental groups. An equal amount of these extracts was added
intobothgroupsaswellasthestandardcurve.Cellstreatedwith10
mM propionate for 1 h showed dramatic increases in propionyl-
CoA levels relative to control cells, with concomitant decreases in
levels of acetyl-CoA, succinyl-CoA, and CoA (Figure 6).
Figure 5. Preparation of a speciﬁc stable isotope labeled CoA thioester stable isotope standard: CoA extracts from stable isotope labeled cells (A)
untreated and (B) treated with 10 mM propionate for 60 min.
Table 3. Assay Validation
a
precision (RSD)
linearity (R
2) intrabatch interbatch LOQ (pmol)
acetyl-CoA 0.9990 2.4% 2.6% 0.1
succinyl-CoA 0.9996 5.6% 1.6% 0.2
CoASH 0.9966 6.8% 2.6% 0.1
propionyl-CoA 0.9999 9.1% 13.9% 0.05
HMG-CoA 0.9939 7.1% 10.4% 0.2
aStandard curves were generated by spiking increasing concentrations
of diﬀerent CoA standards with 0.5 mL of acid-extracted CoA. Pooled
frozen extracts from Hepa cells were thawed and mixed with internal
standard mixture and extracted. Limit of quantitation (LOQ) was
determined to be the level at which the signal-to-noise ratio was 5:1
compared to a blank (Supporting Information Supplemental Figure 1).1368 dx.doi.org/10.1021/ac1027353 |Anal. Chem. 2011, 83, 1363–1369
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’CONCLUSIONS
A SILEC method has been developed for generating labeled
CoA and CoA thioester standards by adapting SILAC metho-
dology to utilize an essential vitamin and an endogenous bio-
synthetic pathway. Isotopically labeled substrates have been
employed previously in tracer experiments to monitor cellular
metabolic ﬂux.
44,45 However, our study has focused on the opti-
mization and scale-up of stable isotope labeled standards with
low levels of the endogenous unlabeled analogues for use in
quantitative assays. By using charcoal-stripped FBS instead of
dialyzed or undialyzed FBS, more eﬀective incorporation of
pantothenate was achieved. The resulting SILEC methodology
employing [
13C3
15N1]-pantothenate (instead of labeled amino
acidsusedinSILACmethodology)madeitpossibletorigorously
quantify short-chain CoA thioesters in cell culture. Although our
analysis was limited to short-chain acyl-CoA species, this ap-
proach could be adapted to analyze medium- or long-chain CoA
thioesters and other CoA-containing species with appropriate
modiﬁcations to the extraction protocol.
32 The availability of
labeled CoASH will also facilitate the development of methodol-
ogy for the quantiﬁcation of this important mitochondrial thiol
and its oxidized mixed disulﬁde derivatives such as CoA-
glutathione.
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